Related Experiment Videos
Intensive treatment for multiple myeloma: where do we stand?
H M Lokhorst1, P Sonneveld, L F Verdonck
1Department of Haematology, University Hospital Utrecht, The Netherlands.
British Journal of Haematology
|August 12, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
European Myeloma Network Group review and consensus statement on primary plasma cell leukemia.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial.
European journal of cancer (Oxford, England : 1990)·2024
Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes
Current oncology (Toronto, Ont.)·2020
Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma.
British journal of haematology·2026
CD47 promotes myeloma cell growth through JAK-STAT3/MYC signalling and is targetable by ruxolitinib.
British journal of haematology·2026
The association between inborn errors of immunity and Hodgkin lymphoma-A register-based case-control study in Sweden.
British journal of haematology·2026
Erratum: Microdystrophins partially rescue deficits of Duchenne muscular dystrophy iPSC-cardiomyocytes.
Molecular therapy. Advances·2026
Mycobacterium abscessus soft tissue infections associated with subcutaneous injection of lipolytic agents: An outbreak report and novel molecular epidemiology analysis approach.
Canada communicable disease report = Releve des maladies transmissibles au Canada·2026
Health related quality of life and cardiac symptoms following admission for suspected MINOCA: A post-hoc analysis of the MINOCA-BAT randomized clinical trial.
American heart journal plus : cardiology research and practice·2026